Aspergillus mastoiditis in a patient with systematic lupus erythematosus: A case report

Skull Base

Volumn 15, Issue 2, 2005, Pages 109-112

  Amonoo Kuofi, Kwamena ^a,b   Tostevin, Phillipa ^a   Knight, Jeff R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Ear; Fungal infection; Immunosuppression; Mastoid; Mycoses; Temporal bone

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; BETAMETHASONE SODIUM PHOSPHATE; EPHEDRINE; GENTISONE HYDROCHLORIDE; PREDNISOLONE; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONDUCTION DEAFNESS; DEBRIDEMENT; DISEASE ASSOCIATION; DISEASE DURATION; EXTERNAL OTITIS; FACIAL NERVE; FEMALE; FOLLOW UP; HEADACHE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MASTOIDECTOMY; MASTOIDITIS; NERVE FUNCTION; OTALGIA; OTITIS MEDIA; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TYMPANOMETRY; UPPER RESPIRATORY TRACT INFECTION;

EID: 21044453773     PISSN: 15315010     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870595     Document Type: Article

References (17)

1. Adams NF Jr. Infections involving the ethmoid, maxillary and sphenoid sinus and the orbit due to Aspergillus fumigatus. Arch Surg 1923;26:999-1009
2. Petrak RM, Pottage JC, Levin S. Invasive external otitis caused by Aspergillus fumigatus in an immunocompromised patient. J Infect Dis 1985;151:196
3. Hall PJ, Farrior JB. Aspergillus mastoiditis. Otolaryngol Head Neck Surg 1993;108:167-170
4. Teh W, Matti BS, Marisiddaiah H, Minamoto GY. Aspergillus sinusitis in patients with AIDS: report of three cases and review. Clin Infect Dis 1995;21:529-535
5. Cunningham M, Yu VL, Turner J, Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg 1988;114:554-556
6. Bryce GE, Phillips P, Lepawsky M, Gribble MJ. Invasive Aspergillus tympanomastoiditis in an immunocompetent patient. J Otolaryngol 1997;26:266-269
7. Hora JF. Primary aspergillosis of the paranasal sinuses and associated areas. Laryngoscope 1965;75:768-773
8. McGill TJ. Mycotic infection of the temporal bone. Arch Otolaryngol 1978;104:140-144
9. Stanley RJ, McCaffrey TV, Weiland LH. Fungal mastoiditis in the immunocompromised host. Arch Otolaryngol Head Neck Surg 1988;114:198-199
10. Slack C, Watson DW, Abzug MJ, Shaw C, Chan KH. Fungal mastoiditis in immunocompromised children. Arch Otolaryngol Head Neck Surg 1999;125:73-75
11. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive Aspergillus with itraconazole. Am J Med 1989;86:791-800
12. Patterson TF. Role of newer azoles in surgical patients. J Chemother 1999;11:504-512
13. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999;12:40-79
14. Ruhnke M. Voriconazole - application and perspectives. Mycoses 2002;45:42-47
15. Johnson LB, Kaufmann CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-637
16. Ullmann AJ. Review of the safety, tolerability and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr Med Res Opin 2003;19:263-271
17. Hoffman HL, Rathbun RC. Review of the safety and efficacy of voriconazole. Expert Opin Investig Drug 2002;11:409-429